Clinical Laserthermia Valuation Multiples

Clinical Laserthermia Overview

About Clinical Laserthermia

Clinical Laserthermia Systems AB develops and sells single-use products used during each treatment procedure of treatment of solid tumors cancers. Its products include Thermal Therapy System, Mobile Laser Unit, Laser Applicator Non-cooled and Tissue Temp Probe.

Founded

2006

HQ

Employees

16

Website

clinicallaser.se

Sectors

Medical DevicesHealthTech

Financials (LTM)

Revenue: $3M

EBITDA: ($2M)

EV

$15M

Valuation Multiples

Multiples.vc

Start free trial

Clinical Laserthermia Financials

Clinical Laserthermia reported last 12-month revenue of $3M and negative EBITDA of ($2M).

In the same LTM period, Clinical Laserthermia generated $2M in gross profit, ($2M) in EBITDA losses, and had net loss of ($4M).

Clinical Laserthermia P&L

In the most recent fiscal year, Clinical Laserthermia reported revenue of $2M and EBITDA of ($3M).

Clinical Laserthermia expects next 12-month revenue of XXX and NTM EBITDA of XXX

Clinical Laserthermia Stock Performance

Clinical Laserthermia has current market cap of $16M, and enterprise value of $15M.

Clinical Laserthermia's stock price is $0.51.

Clinical Laserthermia Valuation Multiples

Clinical Laserthermia trades at 5.6x EV/Revenue multiple, and (5.9x) EV/EBITDA.

Clinical Laserthermia Financial Valuation Multiples

As of April 19, 2026, Clinical Laserthermia has market cap of $16M and EV of $15M.

Equity research analysts estimate Clinical Laserthermia's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Clinical Laserthermia has a P/E ratio of (4.2x).

Clinical Laserthermia Margins & Growth Rates

Clinical Laserthermia's revenue in the last 12 month grew by 134%.

Clinical Laserthermia's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.3M for the same period.

Clinical Laserthermia's rule of 40 is 81% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Clinical Laserthermia's rule of X is 256% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Clinical Laserthermia Public Comps

See public comps and valuation multiples for other Medical Devices comps.

Clinical Laserthermia M&A Activity

Clinical Laserthermia acquired XXX companies to date.

Last acquisition by Clinical Laserthermia was on XXXXXXXX, XXXXX. Clinical Laserthermia acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Clinical Laserthermia Investment Activity

Clinical Laserthermia invested in XXX companies to date.

Clinical Laserthermia made its latest investment on XXXXXXXX, XXXXX. Clinical Laserthermia invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).